首页> 外国专利> New 4-(3-(quinolin-4-yl)-3-oxopropyl)-piperidine derivatives, useful as potent, low toxicity antibacterial agents effective against Gram positive and Gram positive bacteria

New 4-(3-(quinolin-4-yl)-3-oxopropyl)-piperidine derivatives, useful as potent, low toxicity antibacterial agents effective against Gram positive and Gram positive bacteria

机译:新的4-(3-(喹啉-4-基)-3-氧丙基)-哌啶衍生物,可用作有效,低毒的抗菌剂,可有效对抗革兰氏阳性和革兰氏阳性细菌

摘要

1-(Substituted alkyl or propargyl)-4-((3-(6-alkoxy-quinolin-4-yl)-3-oxo-propyl)-piperidine-3-carboxylic acid, -3-acetic acid or -3-methanol derivatives (I) are new. Also new are several classes of intermediates. Quinoline derivatives of formula (I) (including isomers, enantiomers and diastereomers and their mixtures) and their salts are new. R1 = H or F; R2 = COOH, COOMe or CH2OH; R3 = (a) 1-6C alkyl substituted by -S-Ph', S-Cyc or S-Het or (b) propargyl substituted by Ph', Cyc or Het; Ph' = phenyl (optionally substituted by 1-4 of halo, OH, alkyl, alkoxy, CF3, OCF3, COOH, alkoxycarbonyl, CN or NH2); Cyc = 3-7C cycloalkyl (optionally substituted by one or more halo or CF3); Het = 5- or 6-membered heteroaryl containing 1-4 of N, O and/or S as heteroatoms (optionally substituted by one or more of halo, OH, alkyl, alkoxy, CF3, OCF3, COOH, alkoxycarbonyl, CN or NH2); and R4 = 1-6C alkyl, (2-6C) alkenyl-CH2, (2-6C) alkynyl-CH2, 3-8C cycloalkyl or (3-8C) cycloalkyl-alkyl. Independent claims are also included for: (1) Preparation of (I); and (2) Piperidine derivative intermediates of formulae (II; R1 = F) (including corresponding compounds having a protected keto function), (A; K = keto-protecting group), (B; K = keto-protecting group), (C), (VII) and (VIII). R'2 = protected COOH or protected -CH2COOH; K1 = O or keto-protecting group; Rz = amino-protecting group; Ra = 1-4C alkyl; and R'''2 = COOH or CH2COOH (both optionally protected); or CH2OH.
机译:1-(取代的烷基或炔丙基)-4-((3-(6-烷氧基-喹啉-4-基)-3-氧代丙基)-哌啶-3-羧酸,-3-乙酸或-3-甲醇衍生物(I)是新的,还有几类中间体也是新的:式(I)的喹啉衍生物(包括异构体,对映异构体和非对映异构体及其混合物)及其盐是新的。R1 = H或F; R2 = COOH, COOMe或CH2OH; R3 =(a)被-S-Ph',S-Cyc或S-Het取代的1-6C烷基,或(b)被Ph',Cyc或Het取代的炔丙基; Ph'=苯基(可选地被1-4个卤素,OH,烷基,烷氧基,CF3,OCF3,COOH,烷氧羰基,CN或NH2); Cyc = 3-7C环烷基(可选被一个或多个卤素或CF3取代); Het = 5或6-含1-4个N,O和/或S作为杂原子的成员杂芳基(可选被卤素,OH,烷基,烷氧基,CF3,OCF3,COOH,烷氧羰基,CN或NH2中的一个或多个取代); R4 = 1- 6C烷基,(2-6C)烯基-CH2,(2-6C)炔基-CH2、3-8C环烷基或(3-8C)环烷基-烷基。权利要求还包括:(1)制备(I); (2)式(II; R1 = F)的哌啶衍生物中间体(包括具有被保护的酮官能团的相应化合物),(A; K =酮保护基团),(B; K =酮保护基团),( C),(VII)和(VIII)。 R′2 =保护的COOH或保护的-CH 2 COOH; K1 = O或酮保护基; Rz =氨基保护基; Ra = 1-4C烷基; R''2 = COOH或CH2COOH(均可选地被保护);或CH2OH。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号